Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammation, Innate Immunity, MIcrobiota and Inovative Treatments in ENDOmetriosis

NCT07078435 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT07078435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07078435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammation, Innate Immunity, MIcrobiota and Inovative Treatments in ENDOmetriosis
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 9, 2025
Completion date
September 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis, immunity, microbiota